3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
7
Withdrawn
4
Completed
4
Unknown
3
Terminated
3
Not yet recruiting
2
Active not recruiting
2
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Small Cell Lung Carcinoma
1
Recurrent Head and Neck Carcinoma
1
Lung Neoplasms
1
Glioblastoma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
aldesleukin
2
Oxaliplatin
2
Interleukin-2
2
Cetuximab
2
Bevacizumab
2
vactosertib
1
titanium silicide
1
regorafenib
1
fludarabine phosphate
1
encorafenib
1
apatinib
1
Specimen Handling
1
S 1 (combination)
1
Riluzole
1
Radiotherapy
1
Radiosurgery
1
Nivolumab
1
Maintenance
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Irinotecan
1
Interviews as Topic
1
IL32 protein, human
1
Hepatectomy
1
Focus Groups
1
Fluorouracil
1
Flavonoids
1
Cyclophosphamide
1
Colonoscopy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Colorectal Neoplasms
×
Radiosurgery
×
Clear all
NCT05375708
2025-03-28
SIRIUS
UMC Utrecht
Phase 2
Suspended
93 enrolled